Coronavirus | Opeds and editorials

Vaccine optimism and the scientific uncertainty link

With its robust domestic vaccine industry and strong fundamentals of the Universal Immunisation Programme, India is now embarking on the world’s largest COVID-19 vaccination programme, on January 16, 2021. This represents the forging of a novel public-private collaboration wherein the vaccine supply is under the responsibility of Indian pharma companies and the Ministry of Health and Family Welfare for the implementation of the vaccination programme.

The vaccine development programme has received unstinted support from the government, and two vaccines (Covishield and Covaxin) have been granted permission for restricted use in an emergency situation subject to certain regulatory conditions. The clinical trial ongoing within the country by the firms will continue. These vaccines are thus deemed to be market ready while regulatory processes and logistic requirements are being laid out.

Also read | Vaccine dilemma — to take or not to take Covaxin

The expedited development was guided by the “adaptive and seamless” approach advocated by the World Health Organization (WHO) for public health emergencies and promoted by the Central Drugs Standard Control Organisation, and some of the current discourse of regulatory issues is focused on the authorisation process.

Traditional clinical trials follow a straightforward but mandatory three-step approach: designing, conducting and analysing the collected data, according to a pre-specified analysis plan. Seamless adaptive designs add a ‘review-adapt’ loop to the linear design-conduct-analysis sequence, with a pre-defined one primary endpoint and several secondary endpoints. An adaptation is referred to a change made to the trial procedure, such as eligibility criteria, study dose, treatment duration or study endpoints, and/or statistical procedures such as randomisation, study design, study hypothesis or statistical analysis plan, while a clinical trial is at the design stage. These are a priori planned adaptations and should be based on data collected from the study itself, and different from unplanned ad hoc modifications that are common in traditional trials.

Impact of modifications

In the current situation, where the clinical trial of both vaccines shall continue, community engagement is critical to establish community acceptability of control arms, placebo, and blinding and should adhere to WHO’s guidelines on good participatory practice (GPP). Acceptability may impact whether trials are individually or cluster randomised, blinded or unblinded, and have use of a placebo or other comparator. Unique cultural considerations such as drawing of blood may impact the study design, and in turn the choice of endpoints collected in the study.

Comment | Hasty approval, no transparency

There are some key regulatory concerns and the challenge of communicating them to the users and beneficiaries of research including policymakers. What is the level of adaptation that is agreed to by the regulatory agencies? What are the regulatory standards for the review and approval process of data obtained from adaptive trials with different levels of modifications? And, most critically, has the trial become a totally different trial after the modifications for addressing the study objectives of the originally planned clinical trial?

Need for more caution

The European Medicines Agency cautions that while the increased flexibility of this option may well fit the needs in early phases of drug development, their use in late Phase II or confirmatory Phase III trials deserves a more cautionary approach. Pharmacology experts thus opine that “not every trial can be rescued by adaptation and adaptive designs... these should not be a cure for poor planning”. While adaptive designs do have a risk of introducing bias in a trial, that is not to be construed as a reason for staying away from these designs. The challenge is to minimise operational bias by rigorous planning and transparency. There is also a need to build and sustain trust through clear and comprehensive sharing of the adaptive design protocols in scientific journals for peer guidance, particularly in projects with major translational relevance. These challenges are as critical to the regulators as to those designing communication strategies and messages, with obvious implications for vaccine confidence.

Also read | We were in the dark, say Bhopal COVID-19 vaccine volunteers

Given the conditions under which the vaccines are being rolled out, there is considerable debate among scientists, the medical community and the public at large. Among these diverse constituencies, there are optimists and sceptics about the effectiveness and safety of the vaccines. According to WHO, vaccine confidence encompasses trust in the effectiveness and safety of the vaccine as much as in the system that delivers.

Adequacy of processes

An important aspect is also the perceived motivations of policymakers making decisions about the vaccine. Given the fact that data are still awaited on the effectiveness and safety of the vaccine, the rollout decisions may well add to the scepticism. In addition, there is a need for imaginative social and behavioural research that takes on board the scientific uncertainties and helps to build trust in the health service system and the community. Trust-building in the vaccine and its rollout is important for a robust communication strategy. The lack of this does not augur well for programme implementation even while efforts are being made to promote and sustain vaccine demand.

Comment | The purpose of a vaccine

Therefore, it is critical at this stage for the government and establishment scientists to communicate how the regulatory processes and authorisation are adequate and appropriate. Are we, as a community of researchers and policymakers, making adequate and appropriate efforts to communicate these uncertainties? Communicating uncertainty entails identifying facts that are specifically relevant to potential vaccinees, characterising the relevant uncertainties, assessing their magnitude, drafting possible messages and evaluating their success. Underlying the vaccine optimism is the search for a strong signal that the evidence is certain enough and how far the predictions of valued outcomes can be relied upon.

Needed, openness

Scientists are trained and professionalised in dealing with doubt and uncertainty, given that all scientific knowledge is uncertain. To quote Richard Feynman, “... to solve any problem that has never been solved before, you have to leave the door to the unknown ajar. You have to permit the possibility that you do not have it exactly right. Otherwise, if you have made up your mind already, you might not solve it.” The task, particularly in the current context, is to be able to communicate scientific uncertainty — both to policymakers and the public at large. This requires a climate of transparency and data sharing that allows for public scrutiny and a healthy debate.

Rajib Dasgupta and Rama V. Baru are professors at the Centre of Social Medicine and Community Health, Jawaharlal Nehru University, New Delhi. The views expressed are personal

This article is closed for comments.
Please Email the Editor

Printable version | Mar 1, 2021 9:34:30 AM | https://www.thehindu.com/opinion/op-ed/vaccine-optimism-and-the-scientific-uncertainty-link/article33583245.ece

In This Package
Vaccine inequities: On need to vaccinate all above 45
Addressing vaccine reluctance and policy hesitancy
Redefining the exit plan for COVID-19
Boosting confidence: On need for efficient use of COVID-19 vaccine stocks
Opening up the vaccine market
Origin and spread: On the source of SARS-CoV-2
New questions: On COVID-19 infecting one-fifth of Indian population
A year on, mind the gaps in the pandemic response
Should Board exams be conducted in one go this year?
No to vaccine nationalism, yes to global cooperation
Tempered optimism: On India’s sliding COVID-19 graph
The best shot against COVID-19
More vaccines than takers
Managing the rollout: On addressing vaccine hesitancy
Injecting confidence: On India’s COVID-19 vaccination drive
You are reading
Vaccine optimism and the scientific uncertainty link
Building trust in vaccines
The debilitating side-effect of a flawed vaccine trial
Gearing up: On vaccines and public trust
A hurried gamble: On vaccines and transparency
The second dose: On COVID-19 vaccine
A constant vigil: On the new coronavirus strain in India
Unmasked, reflections on the pandemic and life
Caution pays: On Centre’s COVID-19 surveillance guidelines
Towards an effective vaccination distribution policy
Essential dry run: On COVID-19 vaccination drive
COVID-19 and limits of political accountability
The purpose of a vaccine
Clear the fog, draw up a clear vaccination policy
Rein in the vaccine nationalism, the profiteering
In vaccine race last lap, the key steps for India
The storage tale of two vaccines
T-cell immunity and COVID-19
COVID-19, climate and carbon neutrality
Signs of easing: On India’s COVID-19 fight
Has India passed the COVID-19 peak?
Sooner, better: On indigenously developed COVID-19 test kits
The battered Puja economy
Outline of a pandemic fight, by and for citizens
Pandemics and the collective consciousness
Vaccines with a global common good guarantee
Saving lives under the long shadow of the pandemic
Until vaccine: On Unlock 5
The challenge of changing health behaviour
Weighing the costs: On COVID-19 vaccine
The slow and frustrating journey of recovering from COVID-19
Health worker safety deserves a second look
Unlocking campuses: On UGC’s revised academic calendar
Recovery from COVID-19 can be a struggle
Uniting to combat COVID-19
Coronavirus fears and preconception advice
An agriculture-led revival as flawed claim
A necessary pause: On the COVID-19 vaccine race
The uncertainties over COVID-19 numbers
The challenges in counting the dead
COVID-19 deaths may be higher than reported
The many challenges in estimating deaths
Alone at the top: On India’s COVID-19 numbers
The participants we need in Phase 3 trials
Differential impact of COVID-19 and the lockdown
More than a vaccine, it is about vaccination
COVID-19 and a country club India must leave
A quest for order amid cyber insecurity
Adopting a public systems approach to COVID-19
Milestone of a million: On India’s COVID-19 numbers
Testing times: On university exams
Predictions, pandemics and public health
It’s time to flatten the pandemic stereotyping
Viral outrage only spikes the data
Sending the right message
Needed: Clear testing data
The social contract needs to be rewritten
The pandemic is about eyes shut
Joblessness and opportunity in Tamil Nadu
Green-lighting ecological decimation amidst a pandemic
COVID-19 has no religion
A case for extension: On rural jobs scheme
Surely, even if slowly: On a COVID-19 vaccine
Bend it like Italy: On flattening the COVID-19 curve
Promise and delivery: On India’s first COVID-19 vaccine
States hold the key: On Unlock 2.0
PCR testing is a double-edged sword
Science vs nonsense: On Patanjali’s COVID-19 claim
Shut and open: On tennis during the pandemic
The perils of follow the leader syndrome
The many questions about Favipiravir
In new lockdown, a second chance for Tamil Nadu
United front in Delhi: On Kejriwal government-Centre camaraderie
A prescription of equitable and effective care
Multilateralism post COVID-19
Making public transport safe during COVID-19
A better rate: On COVID-19 recovery
Look back in relief: On the migrant labour crisis
Needed, a transfusion for public health care
Wrong priorities: On keeping religious places open during a pandemic
Crossing the line: On Delhi’s decision to limit health services
Profit, not profiteering: On regulation of COVID-19 testing charges
In Persian Gulf littoral, cooperative security is key
Paging the private sector in the COVID fight
Curves and recoveries: On India’s coronavirus numbers
India’s Parliament is missing in action
Axing the economy’s trunk
Scripting a new narrative for COVID control
Open with caution: On Unlock 1
It’s time for a universal basic income programme in India
The waning of subaltern solidarity for Hindutva
Export blocks: On India’s trade amid the pandemic
A moment to trust the teacher
The echo of migrant footfalls and the silence on policy
Enjoying the fruits of their labour
Helping supply chains recover
The heavy burden of social suffering
An effective lockdown
The lockdown has highlighted stark inequalities
Will sport be the same in empty stadia?
Cinema after COVID-19
The eternal longing for the distant home
Working safely: On workplaces during the pandemic
A hole in the whole: On health sector woes
China, better prepared for the post-COVID world
How public health boosts an economy
Keep it retrospective
Backing the ‘angels in white coats’
Standstill: On opening of stadia for training
Flawed stimulus is justice denied
We need social physicians
A callous response
Peaking: On India’s coronavirus tally
Farm gate in focus: On amending Essential Commodities Act
A question of quarantine: On migrant workers and other travellers
TASMAC tribulations: On Tamil Nadu liquor sale
The pandemic and the challenge of behaviour change
One for the poor: On Centre’s corona package
Lockdown syndrome: On virus-induced economic crisis
Are India’s labour laws too restrictive?
Stop the return to laissez-faire
States cannot be left to the Centre’s mercy
Local motif: On Modi’s call for self-reliance
Liquidity lifeline: On Nirmala’s MSME package
A plan to revive a broken economy
Provide income support, restore jobs
Perilous state: On State finances
COVID-19 and the path ahead
Reaffirm cooperative federalism
Riding roughshod over State governments
Tragedy on the tracks: On the killing of 16 migrant workers
Coming to terms: On India refusing to admit community transmission
The trends shaping the post-COVID-19 world
The epidemic and ensuring safety in courts
Responding to COVID-19 at the grassroots
The face of exploitation
Contempt for labour: On dilution of labour laws
Slower growth and a tighter fiscal
Back home: On return of Indian expatriates
Blame game: On Donald Trump’s anti-China rhetoric over COVID-19
Resuscitating multilateralism with India’s help
A war-like state and a bond to the rescue
Fear and loathing in the land of the free
Everyone wants a good stimulus
Rent control amidst pandemic
Slow release: On lockdown 3.0
No comfort in numbers: On Bengal’s coronavirus cases
Pandemics without borders, South Asia’s evolution
India’s disease surveillance system needs a reboot
No relief for the nowhere people
BRICS against COVID-19
Recovering early: On India’s COVID-19 patients
It’s about food, nutrition and livelihood security
Taiwan’s coronavirus protocol shows how it is done
Needed: a pandemic patent pool
Getty Images/iStockphoto
Plasma therapy is no silver bullet
Take care of yourself too, fellow journalists
Strategic shift: On home isolation of mild coronavirus cases
Coping with today, planning for tomorrow
No end in sight: On India’s coronavirus strategy
Vividly imagining the life of migrant workers
A task for South Asia
Privacy concerns during a pandemic
Unlocking justice in the lockdown
Safe return: On migrant worker distress
The outline of another pandemic combat strategy
Pandemic and panic: On Tamil Nadu’s five-city lockdown
Protecting the poor from becoming poorer
Did SARS-CoV-2 begin from a lab?
Protection for protectors: On safety of healthcare workers
Rapid failures: On antibody testing kits
The COVID-19 paradox in South Asia
Fishing in troubled waters during a pandemic
How will India emerge out of the lockdown?
Making doctors wash hands
Locked out of cities, homes and livelihoods
Script of unity: On coronavirus and social prejudices
Exploiting a pandemic: On Trump’s immigration policy
The village is still relevant
A time for planetary solidarity
There may be no going back
No transparency in West Bengal
Focus on the curve: On India’s COVID-19 numbers
Economy in lockdown: On India’s worst case scenario
A shot of hope with a game changing vaccine
Caught in the heightened arc of communal polemics
Singing the corona tune
Helping a lending hand: On RBI’s second lockdown stimulus
A season of change: On IMD forecast system
A virus, social democracy, and dividends for Kerala
Across the gulf: On stranded Indian workers
Virtual reality: On telemedicine
A blueprint to revive the economy
A case to use JEE-Main instead of JEE-Advanced this year
Will the aviation industry recover from the pandemic?
Data-driven reporting during COVID-19
Stress test: On revised lockdown guidelines
Disastrous decision: On Trump halting funds to WHO
Cease the distractions, seize the moment
Getting the containment strategy in India right
In India’s response, a communications failure
Harmonising with nature
End the harassment of farmers now
A narrowing window: On extension of lockdown
Corona bond: On Eurozone COVID-19 rescue package
Halting the march of rumours
Polls during a pandemic
The pandemic and the contours of a health response
Economic liberalisation and its faults
Invasive, alien, most fearsome
Trade in tatters: On the global slump
Wanted, a collective national endeavour
Disingenuous and no antidote
COVID-19 and the crumbling world order
Women’s safety during lockdown
Lives and livelihoods: On economy after lockdown
Stage fright: On denying community transmission
Team India and winning the pandemic battle
In time of need: On hydroxychloroquine export
Will COVID-19 affect the course of globalisation?
Finding a scapegoat in WHO
Curating news for children during pandemic
A time for extraordinary action
For better use: On MPLADS funds
Needed, greater decentralisation of power
A key arsenal in rural India’s pandemic fight
Preparing for exit: On lifting the lockdown
Sanctions and pandemic: On America’s Iran policy
‘A script of action, responsibility and compassion’: Chief Minister Ashok Gehlot writes on Rajasthan’s fight against COVID-19
Taking a long view of the pandemic fight
Ten questions posed by the virus
A different economic approach
Why healthcare workers above 60 should be ‘benched’
Enemy at the gates: On Kerala-Karnataka border row
Reducing farm distress during a pandemic
Why everyone should wear masks
The criticality of community engagement
A niggardliness that is economically unwarranted
The spectre of a post-COVID-19 world
Light and sound: On Narendra Modi’s 9-minute light ceremony
A million and counting: On global coronavirus spread
Safe forests, safe people: On diseases of animal origin
Quarantine and the law
Making the private sector care for public health
Looking east to contain COVID-19
Limits to rugged individualism
Uncritical endorsement: On exodus of migrant workers and the Supreme Court
Beyond the blame game: On the Tablighi Jamaat episode
A long road: On India’s 21-day coronavirus lockdown
The missing notes: On politics and the fight against COVID-19
China’s zero: On China’s lead in containing coronavirus
Unprecedented step: On Wuhan lockdown
The return of the expert
Lessons from Hubei
A pandemic in an unequal India
Faith can’t override public health
Devising a people-centric response to COVID-19
Karnataka CM writes on how the State is fighting the pandemic
Tamil Nadu CM writes on how the State is stopping the pandemic in its tracks
The hunt for a cure begins with telling the truth
COVID-19 and a city’s anatomy
Long live the nation-state
The COVID cycle
Coronavirus | The worst of times, the best of times
It’s also a fight against punitive measures
The age of the neoliberal virus
The deep void in global leadership
Thinking national, acting local
Every man is a part of the main
Beyond social distancing to fight COVID-19
Next Story